Hematopoietic stem/progenitor cells (HSC/P) reside in the bone marrow in distinct anatomic locations (niches) to receive growth, survival and differentiation signals. HSC/P localization and migration between niches depend on cell-cell and cell-matrix interactions, which result from the cooperation of cytokines, chemokines and adhesion molecules. The CXCL12-CXCR4 pathway, in particular, is essential for myelopoiesis and B lymphopoiesis but the molecular mechanisms of CXCL12 action remain unclear. We previously noted a strong correlation between prolonged CXCL12-mediated focal adhesion kinase (FAK) phosphorylation and sustained pro-adhesive responses in progenitor B cells, but not in mature B cells. Although FAK has been well studied in adherent fibroblasts, its function in hematopoietic cells is not defined. We used two independent approaches to reduce FAK expression in (human and mouse) progenitor cells. RNA interference (RNAi)-mediated FAK silencing abolished CXCL12-induced responses in human pro-B leukemia, REH cells. FAK-deficient REH cells also demonstrated reduced CXCL12-induced activation of the GTPase Rap1, suggesting the importance of FAK in CXCL12-mediated integrin activation. Moreover, in FAK flox/flox hematopoietic precursor cells, Cre-mediated FAK deletion resulted in impaired CXCL12-induced chemotaxis. These studies suggest that FAK may function as a key intermediary in signaling pathways controlling hematopoietic cell lodgment and lineage development.
Introduction
A signature characteristic of hematopoietic stem/progenitor cells (HSC/P) is their ability to self-renew and differentiate along hematopoietic cell lineages. HSC/Ps and lineage-committed progenitor cells are located in specialized bone marrow (BM) microenvironments called stem-cell 'niches' that are believed to control cell growth, survival and differentiation by secretion of soluble factors, cell-cell and cell-matrix interactions. The niche-originating signals that influence HSC/P cell cycle and migratory status depend on the crosstalk between multiple ligand-receptor signaling pathways (for example, chemokines, cytokines and adhesion molecules, among others).
1,2 Studies using targeted gene disruption in mice have shown that CXCL12 and its corresponding receptor CXCR4 are essential for B-cell and myeloid-cell lineage development during ontogeny. 3, 4 Moreover, both CXCL12/CXCR4 and VLA-4/VCAM-1 axes are important for normal HSC/P and B-cell progenitor retention in the BM, [5] [6] [7] [8] and it is speculated that homing of leukemic cells is also controlled by both of these pathways. [9] [10] [11] [12] In vivo disruption of CXCL12/CXCR4 and VLA-4/VCAM-1 axes interferes with the retention of HSC/P and B-cell precursors in BM niches, resulting in their egress to periphery. 7, 13, 14 In vitro, CXCL12 induces chemotaxis and VLA-4-dependent adhesion to VCAM-1 in HSC/ Ps and B-cell progenitors, [15] [16] [17] [18] and it is speculated that CXCL12-mediated pro-adhesive interactions might explain in part CXCL12-mediated HSC/P and B-cell progenitor BM lodgment observed in vivo. 13, 19 Despite the significance of CXCL12/CXCR4 and VLA-4/VCAM-1 axes in hematopoiesis, the intracellular signaling pathways underlying hematopoietic progenitor cell lodging and lineage development are poorly understood. Previously, we and others observed that CXCL12 activates focal adhesion kinase (FAK) in various hematopoietic cell lineages, as measured by tyrosine phosphorylation. 15, 20, 21 Furthermore, we demonstrated that the duration of FAK phosphorylation correlates with sustained CXCL12-induced pro-adhesive responses in progenitor B cells. 15 Based on these data, we hypothesized that FAK may mediate CXCL12-induced cellular responses in hematopoietic cells.
FAK plays a fundamental regulatory role in the motility and survival of anchorage-dependent cells, for example fibroblasts. FAK is activated following integrin-mediated adhesion to the extracellular matrix by a process called outside-in integrin signaling. 22 Despite the well-established role of FAK in the integrin-controlled motility of anchorage-dependent cells, the functional role of FAK in the biology of hematopoietic cells remains undetermined, due in part to the early embryonic lethality of FAK-deficient embryos, before hematopoiesis begins. 23 In the present study, we sought to assess the potential role of FAK in chemokine-controlled migration and adhesion in human pro-B acute lymphoblastic leukemia (pro-B ALL) cells as well as normal mouse hematopoietic precursor cells. By specific inactivation of the FAK gene in human pro-B ALL REH cells and murine hematopoietic progenitor cells, we show for the first time that FAK is required for CXCL12-induced responses in hematopoietic cells.
Materials and methods

Reagents
RPMI-1640 medium, Hank's balanced salt solution (HBSS), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), fetal calf serum (FCS), penicillin, streptomycin, L-glutamine, 2-mercaptoethanol (2-ME) were from Invitrogen (Carlsbad, CA, USA). Manganese chloride (MnCl 2 ), puromycin, bovine serum albumin (BSA) and polybrene were from Sigma (St Louis, MO, USA). CXCL12 was from Peprotech (Rocky Hill, NJ, USA).
Retrovirus-mediated RNA interference of FAK and transient transfection with wild-type chicken-FAK in REH cells
Human acute lymphoblastic pro-B cell leukemia (pro-B ALL) REH cell line (CRL8286, ATCC, Manassas VA, USA) was maintained as described. 15 Twenty short-hairpin RNA constructs (shRNA) were designed to silence various regions of the human FAK gene. ShRNA-expressing retrovirus-vector delivery system was employed as described previously. 24 Briefly, 63-nt DNA oligomers (IDT, Coralville, IA, USA) containing the sense sequence, a 9-nt loop (TTCAAGAGA) and the antisense sequence were cloned downstream of the U6 promoter of a modified pBabe-puro retroviral vector. The pBABE-puro-U6-hFAK vectors were co-transfected into phoenix-293T cells with the pCMV-VSVg plasmid. The resulting retrovirus-containing supernatant from the transfected cells was used for the spininfection of REH cells (2500 r.p.m. for 2 h at room temperature), followed by puromycin selection (300 ng/ml) of stably transfected clones. The best silencing efficiency was achieved by shRNA designated as FAK3-RNAi (RNA interference; FAK target sequence: 5-GGAATGCTTCAAGTGTGCT-3), as analyzed by immunoblotting (not shown); therefore, all further studies were conducted using this construct. In some experiments, FAK3-RNAi-bearing REH cells were transiently transfected with hemagglutinin (HA)-tagged chicken FAK (HA-wtFAK) construct (a generous gift from Dr Jun-Lin Guan, University of Michigan Medical School, Ann Arbor, MI, USA), using Lipofectamine 2000 (Invitrogen), according to the manufacturer's specifications.
Western blotting
Western blotting was performed as described previously. 15, 20 Antibodies were anti-FAK (Upstate, Charlottesville, VA, USA), anti-Pyk2, anti-p38 and anti-Rap1 (all three from Santa Cruz Biotechnology, Santa Cruz, CA, USA), phosphospecific (Tyr 397) anti-FAK (Invitrogen's BioSource division) and anti-actin (Sigma). Secondary horseradish peroxidase-conjugated antibodies were from Bio-Rad (Hercules, CA, USA). Enhanced chemiluminescence reagent was from Amersham Biosciences (Piscataway, NJ, USA).
Fluorescence-activated cell sorting analysis
Anti-CD49d (clone P1H4) and anti-CD29 (clone 6S6) antibodies were from Chemicon (Temecula, CA, USA); anti-CXCR4 (clone 12G5) and isotype controls were from BD Biosciences (San Jose, CA, USA). Secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). Acquisition and analysis were performed on MoFlo Cytometer using Summit Software (DakoCytomation, Fort Collins, CO, USA).
Chemotaxis assay
Chemotaxis was performed as described, 17 using Transwell inserts (Costar, Cambridge, MA, USA; 6.5 mm diameter, 5 mm filter pore size), 5 Â 10 5 cells per well and CXCL12 (500 ng/ml final concentration). Cells were allowed to migrate for 2 h at 371C and after that time, cells that passed through the membrane to the lower well were collected and enumerated by timed acquisition (60 s each sample at 2 psi sample pressure differential) on a MoFlo cytometer.
Adhesion assay
The long-term adhesion assay was performed as described. 15 Briefly, 2 Â 10 6 cells per 1 ml of adhesion medium (HBSS buffered with HEPES, supplemented with 0.1% BSA) were stimulated with CXCL12 (1 mM final concentration) for 30 min in suspension and were then added to the VCAM-1-coated wells (1 mg/ml final concentration) and allowed to settle for 30 min at 371C. As a negative control, adhesion medium without CXCL12 was used. Wells were then washed manually and the number of adhered cells was determined using CyQUANT cell proliferation kit (Molecular Probes, Eugene, OR, USA). Fluorescence of the samples was measured by a Microtiter Plate Fluorometer (DYNEX Technologies, Chantilly, VA, USA). The percentage of adhered cells was calculated in relation to the number of cells in the input control. In some experiments, cells were stimulated with 1 mM of MnCl 2 for 10 min and then transferred to VCAM-1-coated wells for 30 min, followed by removal of non-adhered cells and determination of adhered cell number as described for CXCL12-stimulated adhesion.
Rap1 pull-down assay
Cells were stimulated with CXCL12 (500 ng/ml) for indicated times and GTP-bound Rap1 was detected using EZ-Detect Rap1 activation kit (Pierce Biotechnology, Rockford, IL, USA). GTPbound Rap1 was resolved on SDS-PAGE and analyzed by Western blotting.
Isolation of human CD34
þ cells CD34 þ hematopoietic progenitor cells were isolated from BM mononuclear cells that were obtained from healthy volunteers as described previously, 15 with the approval of the local Institutional Review Board. Isolation was carried out using the EasySep CD34 enrichment kit (StemCell Technologies, Vancouver, Canada) according to the manufacturer's protocol. The purity of the resulting population was over 96%.
Lentivirally delivered Cre-mediated FAK deletion in murine FAK flox/flox progenitor B, Sca-1 þ and c-kit þ /lin À (KL) hematopoietic progenitor cells
Mice homozygous for floxed-FAK allele (FAK flox/flox ) were a generous gift from Dr Louis F Reichardt (University of California San Franscisco, CA, USA). Femurs and tibias from 8-week-old FAK flox/flox mice were homogenized and BM cells were filtered through a 70-mm filter. Total BM B cells were isolated by EasySep selection kit (StemCell Technologies) with the purity being over 96%, as assessed by fluorescence-activated cell sorting (FACS) analysis of CD19 expression (data not shown). To obtain a homogenous population of B-cell progenitors, B cells were cultured for 7 days in interleukin (IL)-7-containing complete RPMI medium (RPMI medium supplemented with 20% FCS, 50 mM 2-ME, 2 mM L-glutamine, 1 Â penicillin/ streptomycin and 10 ng/ml of recombinant mouse IL-7 (R&D Systems, Minneapolis, MN, USA), as described. 25 Over 95% of expanded cells represented pro-B/early pre-B cell stage of development (B220 þ , c-kit 26 in which Cre recombinase expression is driven by the CMV promoter and transduction efficiency can be monitored by ZsGreen expression (lenti-Cre vector). Lentiviruses were produced in 293T cells as described. 27 As a control, the mock lentiviral vector (without Cre) was used. The expanded FAK flox/flox progenitor B cells were transduced in RMPI complete medium (viral MOI equal to 100) in the presence of IL-7 (10 ng/ml) and polybrene (5 mg/ml). After 12 h incubation, the supernatants were replaced with fresh medium (containing 10 ng/ml of IL-7) and cells were analyzed at 96 h after transduction. KL and Sca-1 þ cells were transduced as described. 27 Briefly, transduction was performed in serum-free SF34 medium containing 5 mg/ml polybrene, 10 ng/ml stem cell factor (SCF) and 100 ng/ml TPO for 12 h (cytokines were from R&D Systems). After 12 h incubation, the supernatants were replaced with fresh medium and cells were analyzed at 48 h post transduction. For cell viability/apoptosis assessment, cells were stained with Annexin-V-APC and 7-amino actinomycin (7-AAD, BD Biosciences) and analyzed within ZsGreen-positive gate by flow cytometry, according to the manufacturer's protocol. For PCR analysis and chemotaxis assay, ZsGreenpositive cells were isolated by FACS. The efficiency of Cremediated FAK deletion was determined by PCR, as described previously. 28 In vitro progenitor colony-forming assay 29 Lenti-Cre-or mock-transduced KL cells (10 4 ) were plated in quadruplicates in the methylcellulose medium (MethoCult 3236; StemCell Technologies) supplemented with SCF (100 ng/ml). Cultures were incubated at 371C in 5% CO 2 and saturating humidity for 7 days and colonies were then counted under a dissecting microscope, based on morphologic criteria. As reported previously, KL cells cultured with SCF in methylcellulose are enriched for hematopoietic progenitors consisting primarily of granulocyte-and granulocyte/macrophage-colonyforming unit (CFU). 30 This was confirmed by our flow cytometric analysis: 60% of cells plucked from colonies (CFU-SCF cells) were committed myeloid progenitors (c-kit þ /Gr-1 low and/or c-kit þ /Mac-1 low ), whereas 20% of cells retained the initial c-kit þ /linÀ phenotype; the remaining 20% of cells represented mature cells (c-kit-negative/Gr-1 and/or Mac-1-positive, data not shown).
Chemotaxis of transduced progenitor B cells, CFU-SCF and Sca-1 þ cells
The assay was carried out essentially as described for REH cells, using 10 6 cells per well and 300 ng/ml of CXCL12; the optimal concentration of CXCL12 was established in preliminary studies.
Statistical analysis
The values are shown as the mean7s.d. of at least three experiments or as indicated otherwise. Statistical analysis was carried out using Student's t-test.
Results
Efficient silencing of FAK in REH pro-B cells
REH cells express CXCR4 and respond to CXCL12 by chemotaxis and VLA-4-dependent adhesion to VCAM-1. Essential role of FAK in CXCL12-induced responses AM Glodek et al FAK3-RNAi was considered for further studies. Importantly, FAK knockdown did not affect Pyk-2 kinase expression ( Figure 1a , bottom panel), the only known member of the FAK family that shares a high-sequence homology with FAK. 31 
FAK silencing impairs pro-B cell chemotaxis to CXCL12
First, we examined whether FAK deficiency affects CXCL12-induced chemotaxis. As shown in Figure 2a , chemotaxis of empty vector-transduced cells and CTR-RNAi-transduced cells was comparable to that of parent REH cells. In contrast, chemotaxis of FAK3-RNAi-transduced cells was completely blocked. The significant abrogation of chemotaxis was observed for a range of CXCL12 concentrations tested (10-1000 ng/ml, not shown). CXCR4 surface expression was unchanged by FAK deficiency (Figure 2b) . Moreover, the dynamics and degree of CXCL12-induced internalization of CXCR4 receptor were unaffected by knockdown of FAK (not shown). These results indicate that FAK is required for chemotaxis toward CXCL12, whereas ligand-induced internalization of CXCR4 receptor is FAK-independent.
Rescue of the FAK-RNAi phenotype with wild-type FAK
To confirm that the observed phenotype is the result of sequence-specific silencing of FAK gene, we performed a functional rescue experiment in FAK3-RNAi-infected REH cells that demonstrated 80% of FAK silencing and total inhibition of chemotaxis. HA-tagged wild-type FAK (HA-wtFAK) was transiently transfected into FAK3-RNAi cells. Since the HA-wtFAK construct is derived from chicken, it is refractory to FAK3-RNAi processing due to a base-pair mismatch. 32 As shown in the left panel of Figure 2c , introduction of HA-wtFAK into FAK3-RNAi cells resulted in restoration of FAK expression. More importantly, wild-type FAK restored the chemotactic responsiveness to CXCL12 in FAK3-RNAi REH cells (Figure 2c, right panel) . These results confirm the specificity of RNAi-mediated FAK deletion and further suggest that FAK is required in CXCL12-induced responses of leukemic pro-B cells.
FAK is required for CXCL12-induced ALL pro-B cell adhesion to VCAM-1
We previously observed that CXCL12 promotes sustained adhesion to VCAM-1 in REH pro-B cells and primary BM B cells. 15 To test whether FAK deficiency affects CXCL12-induced sustained adhesion, FAK3-RNAi and control cells were subjected to the long-term adhesion assay. In this assay, cells are continuously exposed to CXCL12 before and during cell plating on VCAM-1-coated wells, in order to simulate the cell exposure to CXCL12 within the BM microenvironment. 15, 33 We found that CXCL12-induced adhesion was completely absent in FAK3-RNAi cells, in contrast to parent REH, empty vector-transduced and CTR-RNAi cells (Figure 3a) . The expression of VLA-4 was unaffected by FAK deficiency (Figure 3b) . Importantly, FAK downregulation did not impair VLA-4 function since stimulation with MnCl 2 , which activates integrins by direct action on their extracellular domains, 34 resulted in strong upregulation of adhesion to VCAM-1 in FAK-deficient as well as control cells (Figure 3c ). 
Decreased CXCL12-induced Rap1 activation in FAK-deficient cells
The molecular mechanisms involved in chemokine-induced integrin activation are poorly understood, although several signaling molecules have been shown to participate in this process. [35] [36] [37] [38] Recently, the Ras-like GTPase Rap1 was described to be crucial in chemokine-induced inside-out integrin activation.
39, 40 We thus tested whether silencing of FAK affects CXCL12-induced Rap1 activation. In agreement with previous reports on CXCL12-induced Rap1 activation in hematopoietic cells, 40, 41 we show that CXCL12 induced Rap1 activation in CTR-RNAi cells (Figure 3d ) and in intact REH cells (not shown). In contrast, Rap1 activation in FAK3-RNAi cells was significantly impaired (Figure 3d ). These data provide further evidence of FAK involvement in the CXCL12-induced integrin activation pathway.
Cre/lox-mediated FAK deletion in primary murine B cell progenitors inhibits chemotaxis to CXCL12 (Figure 4c ) and therefore we conclude that neither Cre expression nor FAK gene deletion altered cell viability under these culture conditions. However, similar to what we observed in RNAi-mediated FAK knockdown in human leukemic cell line REH, Cre-mediated FAK deletion significantly decreased progenitor B-cell chemotaxis to CXCL12 (Figure 4d) . Thus, our results provide cumulative evidence for the critical role of FAK in CXCL12-mediated responses in normal and leukemic BM B lymphocytes.
FAK is tyrosine phosphorylated in hematopoietic progenitor cells upon CXCL12 stimulation
To extend our studies in B-lineage cells described above, we also examined FAK function in other hematopoietic cell populations. First, we assessed the effect of CXCL12 stimulation on FAK tyrosine phosphorylation in human (CD34-positive) and murine (Sca-1-positive) hematopoietic progenitors and found that CXCL12 induces FAK tyrosine phosphorylation in both of these subsets (Figure 5a ). The weaker signal in murine Sca-1 þ cells may be related in part to their relatively smaller size and/or to the fact that both antibodies used in the study (that is, antiphospho FAK and anti-FAK), although crossreactive to mouse, were raised against human FAK phosphorylated at tyrosine 397 and total human FAK, respectively, and in our experience, give a weaker signal when used for analyses of murine cells. 
FAK deletion significantly reduces CXCL12-mediated migration of hematopoietic precursor cells
To test whether the reduction in FAK protein expression affects hematopoietic precursor cell responsiveness to CXCL12, we utilized CFU-SCF cells derived form transduced KL cells. As described in Materials and methods, the resultant population (CFU-SCF cells) retains the characteristics of hematopoietic precursors. Before methylcellulose culture in the presence of SCF, KL cells were transduced with either mock or lenti-Cre vector and FAK deletion in KL and in CFU-SCF cells was confirmed as described in the previous paragraph. CFU-SCF cells were then subjected to chemotaxis toward 300 ng/ml of CXCL12. As shown in Figure 5d 
Discussion
Since the cloning of FAK in 1992, [42] [43] [44] much knowledge has been acquired regarding its central role in migration, cell cycle and survival in adherent cells, such as fibroblasts. In these cells, adhesion-induced integrin activation promotes the organization of focal adhesions, which are defined as protein complexes consisting of signaling and adaptor proteins linked to cytoskeleton structures. 45 FAK is a key focal adhesion component that coordinates the transmission of integrin signals and thus determines the dynamics and the extent of motility in attachment-dependent cells. 22 Specifically, FAK is implicated in controlling the cycle of focal adhesion assembly/disassembly and cytoskeletal rearrangements in response to external stimuli mediated by integrins, cytokine receptors and G-protein-coupled receptors. Furthermore, FAK is important for cell survival and cell-cycle progression and has been implicated in the biology of multiple neoplasms, including acute myelogenous leukemia in which the increased FAK expression is associated with poor prognosis. 46, 47 A number of recent studies employing tissue-specific FAK gene targeting have substantiated the importance of FAK in neuronal and endothelial cell biology. 28, 48 In contrast to adherent cells, hematopoietic cells do not form focal adhesion and stress fiber structures 49 and their integrins remain in a non-adhesive state unless activated (for example, by cytokines and/or chemokines). 37 Based on our previous studies in progenitor B cells, we hypothesized that FAK participates in signaling pathways that determine migratory and adhesive status of hematopoietic cells. Here, we demonstrate that FAK deficiency significantly inhibits CXCL12-induced responses in human and mouse pro-B cells and mouse hematopoietic progenitor cells. First, we found that FAK knockdown by RNAi in human ALL pro-B cell line REH impaired CXCL12-induced chemotactic and pro-adhesive responses. Neither the basal cell adhesion to VCAM-1 nor the adhesion to very high VCAM-1 concentrations in the absence of CXCL12 (as a mean to examine outside-in integrin signaling) were affected by FAK deficiency (not shown), suggesting that the CXCL12-FAK pathway may be involved in inside-out integrin activation. This possibility was further substantiated by the observation that CXCL12-mediated activation of Rap1 is decreased in FAK knockdown pro-B cells. Rap1 is a small GTPase of the Ras superfamily, which acts as a potent trigger for inside-out integrin activation, by modulating integrin affinity and/or membrane clustering. 39 FAK may potentially influence the action of Rap1-specific guanine exchange factors (GEFs) or GTPase-activating proteins, either directly or indirectly, through FAK binding partners (for example, p130Cas) that were shown to activate Rap-1 GEFs. 50 Next, we generated FAK-deficient primary B cells, by employing Cre-mediated recombination in IL-7-expanded FAK flox/flox B-cell progenitors. B cells, in which floxed-FAK alleles were efficiently excised, demonstrated a significant decrease in chemotaxis to CXCL12. Thus, the importance of FAK in CXCL12-induced migration observed in the FAK-RNAitreated pro-B cell ALL line was confirmed by an independent method in primary murine progenitor B cells. Also, similar to progenitor B cells, FAK-deficient Sca-1 þ hematopoietic progenitor cells and hematopoietic precursor cells derived from FAK-deficient KL cells in the presence of SCF (CFU-SCF cells) showed significantly decreased migration toward CXCL12. In FAK-deficient pro-B ALL cells (REH), CXCL12-induced migration was completely inhibited, whereas the effect on migration of normal progenitor B cells as well as hematopoietic precursors (CFU-SCF cells), albeit significant, was less dramatic. These data point to potential CXCL12/CXCR4 signaling differences between normal hematopoietic cells and leukemic cells. Similar differences in CXCL12-induced migration between normal hematopoietic versus leukemic cells were reported by Spiegel et al. 11 In this report, Clostridium difficile-derived toxin B, an inhibitor of Rho GTPases, completely attenuated CXCL12-induced chemotaxis of pro-B ALL cells, whereas it had more subtle effect on chemotaxis of normal precursor B cells as well as CD34-positive hematopoietic progenitors. Since FAK is known to regulate the function of Rho GTPases in non-hematopoietic cells, 22 it will be of interest to characterize FAK-Rho interactions in CXCR4-induced signaling in normal and malignant hematopoietic cells.
Because FAK is implicated in cell survival signaling, 22 we examined whether the in vitro conditions used to isolate progenitor cells caused enhanced apoptosis and/or cell death of FAK-deficient hematopoietic cells compared to wild-type cells. Although we determined that this was not the case, FAK may still prove to be an important survival factor in hematopoietic cells in vivo, where the fate of hematopoietic stem and progenitor cells is determined by a dynamic crosstalk between niche-originating cytokines, chemokines and adhesion molecules. 1 In this regard, FAK deletion did not affect the potential of KL cells to form progenitor colonies, suggesting that FAK signaling may be dispensable for intrinsic hematopoietic progenitor cell proliferation in vitro. Similar findings were reported in Rac2-deficient HSC/P cells: the proliferation of Rac2 À/À HSC/P cells in high proliferative potential colonyforming assays was not different from their wild-type counterparts; however, in vivo studies demonstrated that Rac2 À/À HSC/P ability of long-term engraftment was impaired, suggesting that Rac2 plays an important role in HSC/P microenvironmental localization during the engraftment process. 51 In summary, the current studies provide evidence for the importance of FAK signaling in chemotactic and pro-adhesive responses of hematopoietic cells. We conclude that in vivo studies employing FAK-targeted mouse model systems are needed to provide insight into the function of FAK in various aspects of hematopoiesis, including HSC/P homing, engraftment and lineage development.
